Related Experiment Video
Updated: Aug 8, 2026
13:09
Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Basic assessment and screening for substance abuse in the pediatrician's office
1Division of General Pediatrics, State University of New York, Syracuse, USA.
Pediatric Clinics of North America
|April 1, 1995
Summary
Discussions on substance abuse should start prenatally and continue through adolescence, prioritizing education and prevention. Pediatricians must maintain a high suspicion for subtle signs, especially in high-risk youth.
Area of Science:
- Pediatrics
- Adolescent Medicine
- Substance Abuse Research
Background:
- Substance abuse is a significant concern throughout childhood and adolescence.
- Early identification and intervention are crucial for better health outcomes.
- Pediatricians play a vital role in addressing substance use in young patients.
Purpose of the Study:
- To emphasize the importance of early and continuous discussions on substance abuse.
- To highlight the role of pediatricians in identifying and managing substance use disorders.
- To outline key strategies for prevention and intervention in pediatric populations.
Main Methods:
- Review of current literature and clinical guidelines on pediatric substance abuse.
- Emphasis on clinical observation and high index of suspicion for early detection.
- Integration of psychosocial-medical assessments and screening tools.
Main Results:
- Substance abuse discussions should span from prenatal visits to adolescence.
- Subtle signs of substance use necessitate a high index of suspicion in pediatricians.
- Co-occurring psychosocial-medical issues are closely linked to substance use.
Conclusions:
- Preventive strategies and educational efforts are paramount.
- Pediatricians should routinely screen for and address substance use.
- Referral and coordinated follow-up are essential for affected children and adolescents.
Related Concept Videos
01:23Assessment of Respiration
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...